CIA
CORZ icon

Concurrent Investment Advisors’s Core Scientific CORZ Stock Holding History

Concurrent Investment Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
401,348
+38,497
+11% +$906K 0.09% 251
2026
Q1 		$5.43M Buy
362,851
+52,972
+17% +$903K 0.06% 342
2025
Q4 		$4.51M Buy
309,879
+81,633
+36% +$1.42M 0.05% 356
2025
Q3 		$4.09M Sell
228,246
-10,517
-4% -$154K 0.07% 275
2025
Q2 		$4.08M Sell
238,763
-631
-0.3% -$6.31K 0.08% 263
2025
Q1 		$1.73M Sell
239,394
-10,179
-4% -$116K 0.04% 398
2024
Q4 		$3.51M Sell
249,573
-5,161
-2% -$76.2K 0.09% 215
2024
Q3 		$3.02M Buy
254,734
+141,342
+125% +$1.46M 0.09% 230
2024
Q2 		$1.05M Sell
113,392
-4,288
-4% -$21.9K 0.03% 418
2024
Q1 		$417K Buy
+117,680
New +$408K 0.02% 593

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Concurrent Investment Advisors's CORZ Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Core Scientific (CORZ) stake by 11% in Q2 2026, buying an estimated $906K and bringing the position to 401,348 shares worth $10.3M. The position accounts for 0.09% of the portfolio, ranked #251.

Concurrent Investment Advisors first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Concurrent Investment Advisors held 401,348 shares of Core Scientific worth $10.3M as of Q2 2026.
  • Concurrent Investment Advisors bought 38,497 Core Scientific shares in Q2 2026, an estimated $906K.
  • Core Scientific made up 0.09% of Concurrent Investment Advisors's portfolio in Q2 2026, its #251 holding.
  • Concurrent Investment Advisors first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.